https://www.fool.com/investing/2024/03/17/3-unstoppable-stocks-you-can-buy-now-without-any/?source=iedfolrf0000001
Mar 17, 2024 - There's no need for delays in buying these great stocks.
0
fool:-3883354788635643214
0
https://www.zacks.com/stock/news/2241318/madrigal-mdgl-stock-up-as-fda-approves-first-drug-for-nash?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2241318
Mar 15, 2024 - Madrigal Pharmaceuticals' (MDGL) Rezdiffra (resmetirom) is the first and only medicine approved by the FDA for the treatment of NASH.
zc:7416270046843019976
0
https://www.zacks.com/stock/news/2241296/pharma-stock-roundup-azn-s-new-acquisition-fda-updates-for-nvo-lly-and-more?cid=CS-ZC-FT-analyst_blog|stock_roundup-2241296
Mar 15, 2024 - AstraZeneca (AZN) is set to buy a private rare disease drugmaker. FDA delays decision on Lilly's (LLY) donanemab and approves Novo Nordisk's (NVO) Wegovy for reducing cardiovascular risks.
zc:-4303199437016293624
0
https://www.fool.com/investing/2024/03/09/the-best-stocks-to-invest-50000-in-right-now/?source=iedfolrf0000001
Mar 09, 2024 - These stalwart companies can help you grow your wealth.
0
fool:-6220636149424077753
0
https://www.zacks.com/stock/news/2238098/s-p-500-soars-to-new-highs-5-best-stocks-ytd?cid=CS-ZC-FT-etf_news_and_commentary-2238098
Mar 08, 2024 - The S&P 500 soared to new all-time highs on reassuring comments regarding potential interest rate declines. SPDR S&P 500 ETF Trust (SPY), the proxy version of the S&P 500 Index, has risen 8.3% so far this year.
zc:-4418631746276571622
0
https://www.zacks.com/stock/news/2238077/novo-nordisk-nvo-up-on-upbeat-data-from-new-obesity-pill-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2238077
Mar 08, 2024 - Novo Nordisk (NVO) stock rises as it presents encouraging efficacy data on a new investigational oral obesity pill, amycretin, at its Capital Markets Day.
zc:-6632016347588930676
0
https://www.zacks.com/stock/news/2237396/should-you-buy-red-hot-stocks-now-or-wait?cid=CS-ZC-FT-market_edge-2237396
Mar 07, 2024 - After a mesmerizing rally to start 2024, is it too late to buy the hottest stocks?
zc:621933763005313909
0
https://www.zacks.com/stock/news/2236096/nektar-nktr-q4-loss-wider-than-expected-revenue-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2236096
Mar 05, 2024 - Nektar (NKTR) reports a wider-than-expected loss in the fourth quarter of 2023 while revenue beat estimates.
zc:1935006909523816911
0
https://www.fool.com/investing/2024/03/02/is-it-too-late-to-buy-eli-lilly-stock-now/?source=iedfolrf0000001
Mar 02, 2024 - Eli Lilly stock is having a moment, but the company could easily continue soaring.
0
fool:2994529553355192000
0
https://www.zacks.com/commentary/2232353/top-analyst-reports-for-eli-lilly-procter-gamble-morgan-stanley?cid=CS-ZC-FT-research_daily-2232353
Feb 27, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), The Procter & Gamble Company (PG) and Morgan Stanley (MS).
zc:-4727743462274195510
0